Literature DB >> 30218757

Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.

Najiba Mammadova1, Corey M Summers2, Robyn D Kokemuller3, Qing He4, Shaowei Ding5, Thierry Baron6, Chenxu Yu7, Rudy J Valentine8, Donald S Sakaguchi9, Anumantha G Kanthasamy10, Justin J Greenlee11, M Heather West Greenlee12.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by accumulation of misfolded α-synuclein within the central nervous system (CNS). Visual problems in PD patients are common, although retinal pathology associated with PD is not well understood. The purpose of this study was to investigate retinal pathology in a transgenic mouse model (TgM83) expressing the human A53T α-synuclein mutation and assess the effect of α-synuclein "seeding" on the development of retinal pathology. Two-month-old TgM83 mice were intracerebrally inoculated with brain homogenate from old (12-18 months) TgM83 mice. Retinas were then analyzed at 5 months of age. We analyzed retinas from 5-month-old and 8-month-old uninoculated healthy TgM83 mice, and old (12-18 months) mice that were euthanized following the development of clinical signs. Retinas of B6C3H mice (genetic background of the TgM83 mouse) served as control. We used immunohistochemistry and western blot analysis to detect accumulation of α-synuclein, pTauThr231, inflammation, changes in macroautophagy, and cell death. Raman spectroscopy was used to test the potential to differentiate between retinal tissues of healthy mice and diseased mice. This work demonstrates retinal changes associated with the A53T mutation. Retinas of non-inoculated TgM83 mice had accumulation of α-synuclein, "pre-tangle" tau, activation of retinal glial cells, and photoreceptor cell loss by 8 months of age. The development of these changes is accelerated by inoculation with brain homogenate from clinically ill TgM83 mice. Compared to non-inoculated 5-month-old TgM83 mice, retinas of inoculated 5-month-old mice had increased accumulation of α-synuclein (pSer129) and pTauThr231 proteins, upregulated microglial activation, and dysregulated macroautophagy. Raman spectroscopic analysis was able to discriminate between healthy and diseased mice. This study describes retinal pathology resulting from the A53T mutation. We show that seeding with brain homogenates from old TgM83 mice accelerates retinal pathology. We demonstrate that Raman spectroscopy can be used to accurately identify a diseased retina based on its biochemical profile, and that α-synuclein accumulation may contribute to accumulation of pTauThr231 proteins, neuroinflammation, metabolic dysregulation, and photoreceptor cell death. Our work provides insight into retinal changes associated with Parkinson's disease, and may contribute to a better understanding of visual symptoms experienced by patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy in PD retina; Human A53T mutated α-synuclein; Microglial activation in retina; Misfolded α-synuclein; Müller glial activation; Photoreceptor cell loss; Raman Spectroscopy; Retina in Parkinson's Disease; Tau in retina

Mesh:

Substances:

Year:  2018        PMID: 30218757     DOI: 10.1016/j.nbd.2018.09.013

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  11 in total

1.  Regulation of mitochondrial quality following repeated bouts of hindlimb unloading.

Authors:  Megan E Rosa-Caldwell; Jacob L Brown; Richard A Perry; Kevin L Shimkus; Yasaman Shirazi-Fard; Lemuel A Brown; Harry A Hogan; James D Fluckey; Tyrone A Washington; Michael P Wiggs; Nicholas P Greene
Journal:  Appl Physiol Nutr Metab       Date:  2019-07-24       Impact factor: 2.665

2.  Retina as a Model to Study In Vivo Transmission of α-Synuclein in the A53T Mouse Model of Parkinson's Disease.

Authors:  Najiba Mammadova; Thierry Baron; Jérémy Verchère; Justin J Greenlee; M Heather West Greenlee
Journal:  Methods Mol Biol       Date:  2021

3.  Macular ganglion-cell-complex layer thinning and optic nerve integrity in drug-naïve Parkinson's disease.

Authors:  Jee-Young Lee; Jeeyun Ahn; Eun Jin Yoon; Sohee Oh; Yu Kyeong Kim; Beomseok Jeon
Journal:  J Neural Transm (Vienna)       Date:  2019-10-19       Impact factor: 3.575

Review 4.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

Review 5.  Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough.

Authors:  Upasana Ganguly; Sukhpal Singh; Soumya Pal; Suvarna Prasad; Bimal K Agrawal; Reena V Saini; Sasanka Chakrabarti
Journal:  Front Aging Neurosci       Date:  2021-07-08       Impact factor: 5.750

Review 6.  Myeloid cells in retinal and brain degeneration.

Authors:  Michelle Guo; Turner D Schwartz; Joshua L Dunaief; Qi N Cui
Journal:  FEBS J       Date:  2021-09-15       Impact factor: 5.622

7.  Assessment of the Retina of Plp-α-Syn Mice as a Model for Studying Synuclein-Dependent Diseases.

Authors:  Kathrin Kaehler; Hartwig Seitter; Adolf M Sandbichler; Bettina Tschugg; Gerald J Obermair; Nadia Stefanova; Alexandra Koschak
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

Review 8.  Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson's Disease?

Authors:  Yanyan Zhang; Xiaoguang Zhang; Yunhua Yue; Tian Tian
Journal:  Front Neurosci       Date:  2022-02-04       Impact factor: 4.677

9.  Identification of amyloid beta in small extracellular vesicles via Raman spectroscopy.

Authors:  Meruyert Imanbekova; Sorina Suarasan; Tatu Rojalin; Rachel R Mizenko; Silvia Hilt; Meghna Mathur; Paula Lepine; Michael Nicouleau; Nguyen-Vi Mohamed; Thomas M Durcan; Randy P Carney; John C Voss; Sebastian Wachsmann-Hogiu
Journal:  Nanoscale Adv       Date:  2021-06-07

Review 10.  Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes.

Authors:  Alessia Indrieri; Rocco Pizzarelli; Brunella Franco; Elvira De Leonibus
Journal:  Front Neurosci       Date:  2020-10-19       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.